Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 2 |
Apple
AAPL
|
+$949M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$788M |
| 4 |
Microsoft
MSFT
|
+$654M |
| 5 |
Broadcom
AVGO
|
+$568M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.26B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$702M |
| 3 |
Tesla
TSLA
|
+$694M |
| 4 |
Micron Technology
MU
|
+$601M |
| 5 |
Strategy Inc
MSTR
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.3% |
| 2 | Technology | 1.97% |
| 3 | Financials | 0.89% |
| 4 | Consumer Discretionary | 0.83% |
| 5 | Healthcare | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Vanguard Total International Bond ETF
BNDX
$82.5B
| $5.48M | ﹤0.01% |
111,780
-440,993
| -80% | -$22.1M |
|
3452
CALL
Medpace
MEDP
$16.8B
| $5.48M | ﹤0.01% |
16,500
+5,100
| +45% | +$1.73M |
|
3453
ProShares UltraPro Russell2000
URTY
$325M
| $5.48M | ﹤0.01% |
111,386
+69,757
| +168% | +$3.9M |
|
3454
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$643M
| $5.48M | ﹤0.01% |
60,858
+56,585
| +1,324% | +$6.66M |
|
3455
PUT
Summit Therapeutics
SMMT
$11B
| $5.48M | ﹤0.01% |
306,800
-304,300
| -50% | -$5.9M |
|
3456
State Street SPDR S&P Dividend ETF
SDY
$22B
| $5.46M | ﹤0.01% |
41,360
+21,930
| +113% | +$3.06M |
|
3457
Etsy
ETSY
$7.67B
| $5.46M | ﹤0.01% |
103,247
-382,104
| -79% | -$20.4M |
|
3458
TransAlta
TAC
$3.86B
| $5.46M | ﹤0.01% |
385,683
+331,554
| +613% | +$3.78M |
|
3459
CALL
Rush Street Interactive
RSI
$3.05B
| $5.45M | ﹤0.01% |
397,200
+239,100
| +151% | +$2.91M |
|
3460
PUT
Warby Parker
WRBY
$3.09B
| $5.44M | ﹤0.01% |
224,800
-58,100
| -21% | -$1.19M |
|
3461
CALL
Schwab US Large-Cap Growth ETF
SCHG
$63.1B
| $5.44M | ﹤0.01% |
195,200
-187,200
| -49% | -$5.12M |
|
3462
RUM Group Inc
RUM
$4.45B
| $5.44M | ﹤0.01% |
417,835
+45,784
| +12% | +$326K |
|
3463
Invesco NASDAQ 100 ETF
QQQM
$104B
| $5.43M | ﹤0.01% |
25,815
+24,097
| +1,403% | +$5.02M |
|
|
SKX
3464
DELISTED
Skechers
SKX
| $5.43M | ﹤0.01% |
80,790
+37,418
| +86% | +$2.43M |
|
3465
Corvus Pharmaceuticals
CRVS
$1.19B
| $5.43M | ﹤0.01% |
1,015,083
+796,121
| +364% | +$5.94M |
|
3466
CALL
Nurix Therapeutics
NRIX
$2.72B
| $5.43M | ﹤0.01% |
288,000
+226,300
| +367% | +$5.19M |
|
3467
CALL
Kaspi.kz JSC
KSPI
$20.2B
| $5.42M | ﹤0.01% |
57,200
-16,500
| -22% | -$1.76M |
|
3468
Tecnoglass Holdings
TGLS
$1.78B
| $5.4M | ﹤0.01% |
68,108
+5,346
| +9% | +$407K |
|
3469
CALL
Dycom Industries
DY
$8.88B
| $5.4M | ﹤0.01% |
31,000
-15,600
| -33% | -$2.89M |
|
3470
PUT
iQIYI
IQ
$888M
| $5.39M | ﹤0.01% |
2,683,400
+1,514,000
| +129% | +$3.59M |
|
3471
PUT
Brookfield
BN
$92.3B
| $5.38M | ﹤0.01% |
140,550
+14,400
| +11% | +$542K |
|
|
MSTZ
3472
PUT
T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ
$57.7M
| $5.38M | ﹤0.01% |
+191,500
| New | +$16.4M |
|
3473
Upwork
UPWK
$1.13B
| $5.38M | ﹤0.01% |
328,924
+131,343
| +66% | +$1.89M |
|
3474
CALL
Saia
SAIA
$9.37B
| $5.38M | ﹤0.01% |
11,800
-15,500
| -57% | -$7.67M |
|
3475
State Street SPDR S&P China ETF
GXC
$474M
| $5.37M | ﹤0.01% |
70,788
+12,368
| +21% | +$989K |
|
Similar funds
Jeff Yass's Q4 2024 Portfolio in Review
As of Q4 2024, Jeff Yass held 13,659 positions worth $663B, up 16% from $572B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q4 2024 filing shows 1,862 new, 5,386 increased, 4,790 reduced and 1,590 closed positions. Its largest new stake was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $1.26B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 94% a quarter earlier, followed by Technology and Financials.
- Jeff Yass's largest Q4 2024 buy was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M.
- Jeff Yass added most to Invesco QQQ Trust in Q4 2024, an estimated $1.41B increase.
- Jeff Yass's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.26B.
- Jeff Yass fully exited NextEra Energy 7.299% Corporate Units in Q4 2024, selling an estimated $112M.
- Jeff Yass's ten largest holdings make up 28% of its $663B portfolio in Q4 2024.
- Jeff Yass opened 1,862 new positions and closed 1,590 in Q4 2024.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $663B.
Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.